Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Although existing clinical evidence shows that the transfusion of blood components is becoming increasingly safe, the risk of transmission of known and unknown pathogens, new pathogens or re-emerging pathogens still persists. Pathogen reduction technologies may offer a new approach to increase blood safety. The study is the output of collaboration between the Italian National Blood Centre and the Post-Graduate School of Health Economics and Management, Catholic University of the Sacred Heart, Rome, Italy.

[Documentation and biolaw: achievements and perspectives].

Law is more and more implicated in bioethical issues, as demonstrated by the creation of the word "biolaw". One of the most evident aspects of this discipline lies in the extensive production of documents of different kind and provenance (national laws, EU and international regulations). Hence the necessity and interest of collecting this material, for the purpose of facilitating researches on one or more biolaw issues.